<DOC>
	<DOCNO>NCT00183430</DOCNO>
	<brief_summary>This study evaluate effectiveness prazosin treat post-traumatic stress disorder cause noncombat trauma individual take selective serotonin reuptake inhibitor .</brief_summary>
	<brief_title>Prazosin Treating Noncombat Trauma Post-Traumatic Stress Disorder</brief_title>
	<detailed_description>Post-traumatic stress disorder ( PTSD ) anxiety disorder develop exposure terrify event grave physical harm occur threaten . People PTSD persistent frighten thought memory past ordeal often feel emotionally numb , especially people close . PTSD first recognize male combat veteran . Today , however , majority people PTSD young woman experience non combat-related trauma , sexual physical assault life-threatening illness accident . The disorder short-lived , PTSD also become chronic , long lasting symptom often treatment-resistant , possibly cause severe functional disability . Frequent trauma-related nightmare debilitate sleep disruption examples chronic PTSD symptom effective treatment develop . Sertraline paroxetine , selective serotonin reuptake inhibitor ( SSRIs ) , drug approve FDA treat PTSD . Neither , however , effective reduce PTSD-related sleep disruption . Studies show drug prazosin effective reduce distress trauma-related nightmare old male combat veteran . This study evaluate effectiveness prazosin treat post-traumatic stress disorder cause noncombat trauma individual already treat SSRIs . Participants double-blind study first undergo 12 week treatment psychotherapy standard SSRI . After 12 week , participant randomly assign receive either prazosin placebo addition psychotherapy standard SSRI treatment total 8 week . Study visit occur weekly first 12 week , Weeks 1 , 2 , 4 , 6 , 8 8-week phase . Additionally , follow-up visit hold 4 18 week post-intervention . PTSD symptom , disorder severity , frequency sleep disturbance assess .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Prazosin</mesh_term>
	<criteria>Diagnostic Statistical Manual Mental DisordersIV ( DSMIV ) diagnosis PTSD , derive ClinicianAdministered PTSD Scale ( CAPS ) Stabilized necessary medication least 4 week prior study entry Score great 4 CAPS Recurrent Distressing Dreams item ( maximum score 8 ) Score great 4 CAPS Difficulty Falling Staying Asleep item ( maximum score 8 ) Agrees use effective form contraception throughout study Any acute significant chronic medical illness Any unstable medical condition Unstable angina , recent heart attack , history congestive heart failure , preexist hypotension ( systolic blood pressure le 110 mm Hg ) , orthostatic hypotension Insulindependent diabetes Chronic kidney liver failure Pancreatitis gout Meniere 's disease , benign positional vertigo , narcolepsy Allergy previous adverse reaction prazosin alpha1 antagonist Currently take another alpha1 antagonist agent Pregnant DSMIV diagnosis cognitive disorder , schizophrenia , schizoaffective disorder , bipolar disorder , psychotic disorder Current delirium Active substance dependence disorder within 3 month study entry Current substance use alcohol ( 2 drink per day ) Severe psychiatric instability situational life crisis , include evidence suicidal homicidal ideation Currently take psychotropic medication ( e.g. , antidepressant , benzodiazepine , anticonvulsant , antipsychotic , sedate antihistamine , sedatives/hypnotics ( exclusionary medication discontinue participant undergo 2week washout period baseline assessment )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Prazosin</keyword>
	<keyword>Sleep Disorders</keyword>
</DOC>